Pricing Log in Create free account

Coya Therapeutics, Inc. (COYA) vs PMV Pharmaceuticals, Inc. (PMVP)

Coya Therapeutics, Inc. and PMV Pharmaceuticals, Inc. are both Biotechnology companies. Coya Therapeutics, Inc. and PMV Pharmaceuticals, Inc. are of similar size ($101.8M and $97.4M). PMV Pharmaceuticals, Inc. has the higher net margin (0.00% vs −270.2%) and the higher return on invested capital (0.00% vs −15,230.9%). Across the 13 metrics below, Coya Therapeutics, Inc. leads on 7 and PMV Pharmaceuticals, Inc. on 6.

Valuation

Metric COYA PMVP Biotechnology median
P/E n/m n/m 8.50
P/S 12.49 n/m 9.71
P/B 2.31 0.90 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m 0.18 0.64
EV/Sales 8.72 n/m 9.21
Earnings yield (25.06%) (117.36%) (33.15%)
Free cash flow yield (17.74%) (110.32%) (25.50%)

Profitability

Metric COYA PMVP Biotechnology median
Gross margin 100.00% 0.00% 65.16%
Operating margin (288.70%) 0.00% 0.00%
Net margin (270.22%) 0.00% 0.00%
Free cash flow margin (221.64%) 0.00% 0.00%
Return on equity (60.54%) (70.93%) (56.36%)
Return on assets (53.66%) (64.04%) (48.04%)
Return on invested capital (15,230.92%) 0.00% 0.00%

Growth

Metric COYA PMVP Biotechnology median
Revenue growth (TTM) 108.35% — 6.02%
EPS growth (last fiscal year) (29.59%) (29.82%) 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric COYA PMVP Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 13.40 7.70 4.72
Net debt to EBITDA 2.08 1.27 0.96

Dividend

Metric COYA PMVP Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric COYA PMVP Biotechnology median
Market cap 101.80m 97.42m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack